NCT00815347 - Bosentan for Poorly Controlled Asthma | Biotech Hunter

Enrollment

11

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Asthma

Interventions

DRUG

bosentan

Bosentan 62.5mg or placebo orally, twice a day for four weeks. After four weeks at this dose the subjects will have an increase to bosentan 125 mg or placebo orally twice daily for another four weeks. At week eight, subjects will crossover to bosentan or placebo depending upon their first randomization.

DRUG

placebo

Bosentan 62.5mg or placebo orally, twice a day for four weeks. After four weeks at this dose the subjects will have an increase to bosentan 125 mg or placebo orally twice daily for another four weeks. At week eight, subjects will crossover to bosentan or placebo depending upon their first randomization.

Trial Locations (1)

06030-2810

University of Connecticut Health Center, Farmington